| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |